Method Article

A Protocol for Transcranial Photobiomodulation Therapy in Mice

12.3K views

⸱

DOI:

10.3791/59076

⸱

November 18th, 2018

 ,  ,  ,  ,  ,  ,  , 
1Neurosciences Research Center, Tabriz University of Medical Sciences, 2ProNeuroLIGHT LLC, 3LiteCure LLC, 4Department of Psychiatry, Harvard Medical School, 5Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, 6Center for Anxiety and Traumatic Stress Disorders, Department of Psychiatry, Massachusetts General Hospital, 7Research Institute for Applied Physics and Astronomy, University of Tabriz, 8Department of Medical Physics, Tabriz University of Medical Sciences, 9Department of Medical Bioengineering, Tabriz University of Medical Sciences, 10School of Medical Sciences, University of Aberdeen

In This Article

Summary

Photobiomodulation therapy is an innovative noninvasive modality for the treatment of a wide range of neurological and psychiatric disorders and can also improve healthy brain function. This protocol includes a step-by-step guide to performing brain photobiomodulation in mice by transcranial light delivery, which can be adapted for use in other laboratory rodents.

Abstract

Transcranial photobiomodulation is a potential innovative noninvasive therapeutic approach for improving brain bioenergetics, brain function in a wide range of neurological and psychiatric disorders, and memory enhancement in age-related cognitive decline and neurodegenerative diseases. We describe a laboratory protocol for transcranial photobiomodulation therapy (PBMT) in mice. Aged BALB/c mice (18 months old) are treated with a 660 nm laser transcranially, once daily for 2 weeks. Laser transmittance data shows that approximately 1% of the incident red light on the scalp reaches a 1 mm depth from the cortical surface, penetrating the dorsal hippocampus. Treatment outcomes are assessed by two methods: a Barnes maze test, which is a hippocampus-dependent spatial learning and memory task evaluation, and measuring hippocampal ATP levels, which is used as a bioenergetics index. The results from the Barnes task show an enhancement of the spatial memory in laser-treated aged mice when compared with age-matched controls. Biochemical analysis after laser treatment indicates increased hippocampal ATP levels. We postulate that the enhancement of memory performance is potentially due to an improvement in hippocampal energy metabolism induced by the red laser treatment. The observations in mice could be extended to other animal models since this protocol could potentially be adapted to other species frequently used in translational neuroscience, such as rabbit, cat, dog, or monkey. Transcranial photobiomodulation is a safe and cost-effective modality which may be a promising therapeutic approach in age-related cognitive impairment.

Introduction

PBMT, or low-level laser light therapy (LLLT), is a general term which refers to therapeutic methods based on the stimulation of biological tissues by light energy from lasers or light-emitting diodes (LEDs). Almost all PBMT treatments are applied with red to near-infrared (NIR) light at wavelengths from 600 to 1100 nm, an output power ranging from 1 to 500 mW, and a fluence ranging from <1 to >20 J/cm2 (see Chung et al.1).

Transcranial PBMT is a noninvasive light delivery method that is conducted by irradiation of the head using an external light source (laser or LEDs)2. For animal applications, this method includes contact or noncontact placement of the LED or laser probe on the animal's head. Depending on the therapeutic region of interest, a light probe can be placed either over the entire head (for covering all the brain areas) or over a specific portion of the head, such as the prefrontal, frontal, or parietal region. The partial transmission of red/NIR light through the scalp, skull, and dura mater can reach the cortical surface level and provide an amount of photon energy sufficient to produce therapeutic benefits. Subsequently, the delivered light fluence at the cortical level would be propagated into the gray and white brain matter until it reaches the deeper structures of the brain3.

Light in the spectral bands at the red to far-red region (600-680 nm) and early NIR region (800-870 nm) corresponds to the absorption spectrum of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain4. It is hypothesized that PBMT in the red/NIR spectrum causes photodissociation of nitric oxide (NO) from cytochrome c oxidase, resulting in increases in mitochondrial electron transport and, ultimately, increased ATP generation5. With respect to neuronal applications, the potential neurostimulatory benefits of brain PBMT using transcranial irradiation methods have been reported in a variety of preclinical studies, including rodent models of traumatic brain injury (TBI)6, acute stroke7, Alzheimer's disease (AD)8, Parkinson's disease (PD)9, depression10, and aging11.

Brain aging is considered a neuropsychological condition that negatively affects some cognitive functions, such as learning and memory12. Mitochondria are the primary organelles responsible for ATP production and neuronal bioenergetics. Mitochondrial dysfunction is known to be associated with age-related deficits in brain areas that are linked to spatial navigation memory, such as the hippocampus13. Because cranial treatment with red/NIR light primarily acts by modulation of mitochondrial bioenergetics, sufficient delivered light dosage to the hippocampus can result in the improvement of spatial memory outcomes14.

The aim of the current protocol is to demonstrate the transcranial PBMT procedure in mice, using low levels of red light. The required laser light transmission measurements through the head tissues of aged mice are described. Additionally, Barnes maze, as a hippocampus-dependent spatial learning and memory task, and hippocampal ATP levels, as a bioenergetics index, are used for an evaluation of the treatment impact in animals.

Access restricted. Please log in or start a trial to view this content.

Protocol

All of the procedures were carried out in conformity with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH; Publication No. 85-23, revised 1985) and approved by the regional ethics committee of Tabriz University of Medical Sciences.

CAUTION: This protocol includes the application of Class 3B laser instruments and will require proper training and adherence to safety guidelines. Class 3B lasers can seriously damage the eyes and can heat the skin. Class 3B lasers are not considered a burn hazard. Eye protection goggles must be worn at all times when operating the laser device.

1. Laser light transmission experiments

NOTE: Used here were three 18-month-old male BALB/c mice obtained from the animal facility of Tabriz University of Medical Sciences. A 60 mW laser (660 nm) with a circular beam shape of 2.5 mm in diameter is used as the light source. The laser source produces a circularly polarized light with a Gaussian intensity profile and is operated in continuous wave mode. A commercial photodiode power meter with a 10 nW resolution, a square 1 cm2 photodiode active area, and a spectral response range from 400 to 1100 nm is used to measure the transmitted light power through the samples.

  1. Sample preparation
    1. In order to obtain fresh samples, deeply anesthetize the mouse with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg).
    2. Dissect the mouse's head with regular scissors, starting from the point located just above the shoulders.
    3. Rotate the head so that the ventral side of the jaw faces up. Slide angled dissection scissors smoothly through the oral cavity until the resistance of the mandibular junction is noticed. Cut all large muscles linking the mandible bone to the skull and discard them.
    4. Remove the palatine bones, using angled dissection scissors.
    5. Discard all flesh surrounding the skull, using curved forceps.
    6. Dissect the lower portion of the skull, and then, carefully take the brain out of the remaining skull bone, with a curved spatula.
    7. Fix the intact brain tissue in a 2% agarose gel so the tissue will be suitable for slicing.
      NOTE: In order to obtain an intact skull plus scalp sample, the brain tissue should be removed from the ventral side of the animal's head without any damage to the dorsal portion of the head.
  2. Brain slicing procedure
    1. Spread a drop of superglue (~0.05 mL) on the surface of the vibratome mounting block.
    2. Carefully attach the agarose block to the vibratome mounting block so that the ventral surface of the brain is facedown, and adjust its position.
    3. Slightly match the vibratome blade to the upper surface of the agarose block and record the cutter value as the primary level.
    4. Fill the vibratome tank with ice-cold normal saline solution.
    5. Adjust the vibratome parameters (e.g., the slice thickness [1 mm], speed [5 of 5 on device unit], and vibration frequency [5 of 5 on device unit]) to obtain satisfactory slicing.
    6. Cut the brain transversely into a slice with a 1,000 µm thickness.
      NOTE: The slice is the portion of the brain tissue delimited by the cortical surface and a plane positioned 1,000 µm inferior to the cortical surface (the dorsal hippocampus).
    7. Add a drop of water (~0.05 mL) on the optical glass surface and put the brain slice on top of it. Then, add a drop of water on the brain slice and carefully place the second optical glass on top of it.
      NOTE: A drop of water should be added to the sample glass boundaries in order to prevent tissue drying and light scattering from rough surfaces.
  3. Measurement of light transmission through the head tissues
    1. Set up the optical equipment, including the laser device, reflecting mirrors, and power meter unit.
      CAUTION: Put on protective eye goggles prior to turning on the laser.
    2. In the absence of a sample on the power meter, turn on the laser device and focus the laser beam on the mirror that is located at the proper distance for guiding the beam perpendicular to the photodiode's active area.
      NOTE: Light transmission measurements must be performed in a darkroom at room temperature (23-25 °C), within 30 min after the head tissues have been extracted.
    3. Perform measurements on the sliced brain tissue.
      1. Place two blank optical glasses on the surface of the power meter.
      2. Read the transmitted light power (I0) from the power meter's display screen and record the value.
      3. Gently place the brain sample, which is encompassed by two optical glasses, on the surface of the power meter, focus the beam on the tissue's respective area, read the transmitted power, and record the value.
    4. Perform measurements on the skull plus the scalp.
      1. Place a blank optical glass on the surface of the power meter.
      2. Read the transmitted light power (I0) from the power meter's display screen and record the value.
      3. Lightly place an optical glass with fresh skull plus scalp tissue on the surface of the power meter, match the light beam on the bregma zone, read the transmitted power, and record the value.
      4. In order to maximize the signal-to-noise ratio, repeat the light transmission measurement at least 3x for all samples.
        NOTE: The bregma zone is placed in an approximately 3 mm rostral to a line drawn through the anterior base of the ears. The thickness of the skull plus scalp tissue is measured by a standard caliper.

2. Photobiomodulation therapy (PBMT)

NOTE: Forty-five male BALB/c mice assigned to three groups of 15 mice each were used. The groups were composed of young-control mice (2 months old) that received sham-PBMT, aged-control mice (18 months old) that received sham-PBMT, and aged-PBMT mice (18 months old) that received PBMT. The sham-PBMT treatment consisted of treatment identical to the PBMT group but with the laser inactive. Mice were obtained from the animal facility of Tabriz University of Medical Sciences and were housed in the animal holding unit of the Neurosciences Research Center (NSRC) at 24-25 °C and 55% relative humidity, with a 12 h light and 12 h dark photoperiod. Food and water were provided ad libitum. All mice were acclimatized for at least 1 week prior to treatment.

  1. Laser treatment procedure
    NOTE: A diode GaAlAs laser with continuous wave mode at 660 nm wavelength was used for transcranial PBMT treatment. The laser device was operated at an output power of 200 ± 2 mW and an irradiance of 6.66 W/cm2, with a spot size of 0.03 cm2. An average fluence of 99.9 J/cm2 per each session was delivered to the scalp surface for 15 s of irradiation. The irradiation was administered 1x daily for 2 consecutive weeks.
    1. Bring the mice in their home cages to the therapy room, approximately 20 min prior to beginning the treatment.
    2. Connect an electric protector to the wall outlet.
    3. Insert the laser device plug into an electric protector.
    4. Cover the tip of the laser probe with a transparent nylon film in order to prevent any scratching to the surface.
    5. Carefully connect the probe to the channel of the laser device.
    6. Turn on the laser device and wait a few seconds for it to warm up.
    7. Adjust the laser/treatment parameters, including the irradiation time and operation mode.
    8. In the absence of any samples, determine the laser average power by contacting the tip of the probe to the active area of the power meter on the laser device. Record the value.
    9. Repeat the calibration process (step 2.1.8) at least 5x, read the incident powers from the power meter's display screen, and record the values.
    10. Gently hold a mouse by the dorsal skin of the animal's neck in the palm of a hand and immobilize its head.
      NOTE: In the current protocol, the laser probe is placed on the bregma zone, which is ~3 mm rostral to a line drawn between the internal base of the ears.
    11. Lightly place the tip of the probe directly on the scalp at the midline, approximately 3 mm rostral to a line drawn through the anterior base of the ears.
      NOTE: Hold the probe at an approximately 45° angle to the plane of the abdomen.
    12. In order to avoid direct irradiation to the animal's eyes, first contact the tip of the probe on the head and, then, turn on the laser device.
    13. Turn on the laser and stably hold the probe until the completion of the irradiation.
    14. After the end of the therapy, withdraw the laser probe from the head and gently return the mouse to its cage.
    15. Turn off the laser device and disconnect the probe from the device.
    16. Clean the laser probe with an appropriate optical cleaner.
    17. Transfer the mice to the animal facility.

3. Behavioral Tasks

  1. Open-field test
    1. Assess the locomotor activity of each mouse by the total distance traveled during an open-field test, as described previously15.
  2. Barnes maze task
    1. ​Apparatus
      NOTE: The spatial learning and memory task is performed in a Barnes maze16. The apparatus used for this neurobehavioral task consists of a circular platform made of black wood (95 cm in diameter) with 20 equidistant, 5 cm-diameter circular holes that are located on the platform, 3 cm from the perimeter. The apparatus is elevated 50 cm from the floor to prevent the animal from climbing down. A movable black plastic escape box (20 cm x 15 cm x 5 cm) is placed under the escape hole. A black maze is used for testing white mice, and a black mat should be placed under the maze when a software tracking system is used.
      1. Place the maze apparatus in the center of a quiet room with bright overhead lighting.
      2. Place a "Do Not Enter" sign on the outside of the task room door.
      3. Attach visual-spatial cues to the perimeter walls.
      4. Position a digital video camera above the maze platform.
      5. Clean the surface of the maze platform with 70% ethanol to remove unwanted olfactory cues.
      6. Add a small amount of bedding from the animal's home cage to the inside of the escape box to serve as an olfactory cue.
    2. Adaptation session
      1. Bring each mouse to the task room approximately 30 min prior to beginning the experiment, in order for the mouse to become habituated.
      2. Remove the mouse from its cage and gently place the animal in the escape box for 1 min.
    3. Training session
      NOTE: The training session is repeated for each mouse on 4 consecutive days.
      1. Gently remove the mouse from the escape box.
      2. Place the mouse in the center of the arena; then, place the start chamber on top of the mouse.
      3. Remove the start chamber after 10 s, and allow the mouse to explore the arena for 3 min.
      4. Quietly move to the computer area and put on noise-canceling headphones.
      5. Trigger a negative auditory stimulus consisting of a loud white noise of approximately 80 dB at the platform level and begin videotaping the mouse.
      6. Turn off the white noise and stop videotaping when the mouse enters the escape box. Allow the animal to remain undisturbed in the box for 1 min.
      7. Remove the mouse from the escape box and place it back into its cage.
      8. Repeat steps 3.4.2 through 3.4.7 4x per day, with 3 min intervals between repeated trials.
        NOTE: Between all trials, remove any urine or feces from the arena surface and clean the maze with 70% ethanol.
    4. Probe trial session
      1. Following the last training trial, 24 h later, remove the escape box from the maze platform and repeat steps 3.4.2 through 3.4.5.
      2. After 3 min, turn off the white noise and stop videotaping. Remove the mouse from the maze arena and place it back into its cage.
      3. After all the animals have been tested, clean the maze platform and the start chamber. Turn off the room lights and remove the "Do Not Enter" sign from the door.
      4. Store the video recordings from the testing sessions to an external hard drive for further analysis.
      5. Set up the video-tracking software program and extract the parameters of interest from the recorded videos, including the latency time to find the target hole during 4 days of training sessions and the time spent in the target quadrant during the probe trial session.

4. Biochemical assessment

  1. ATP levels in the hippocampus
    1. Deeply anesthetize each mouse with an intraperitoneal injection of a mixture of ketamine (100 mg per gram of body weight) and xylazine (10 mg per gram of body weight).
    2. Decapitate the animal and rapidly remove the brain tissue from the skull.
    3. Dissect out the hippocampus and homogenize the tissue in ice-cold sample buffer (provided by the kit) with a tissue homogenizer.
    4. Immediately centrifuge the homogenate at 2,000 x g for 3 min at 4 °C.
    5. Transfer the supernatant to a clean tube.
    6. Assess the hippocampal ATP levels, using the spectrophotometric method as described previously11.

Access restricted. Please log in or start a trial to view this content.

Results

Statistical analyses

The statistical analysis of data obtained from the Barnes training sessions was analyzed by two-way ANOVA; the other behavioral tests and analysis of hippocampal ATP levels among groups were carried out by one-way ANOVA, followed by Tukey's post hoc test. All data are expressed as means ± the standard error of the mean (SEM), except for the laser transmission data, which are shown a...

Access restricted. Please log in or start a trial to view this content.

Discussion

We describe a protocol for conducting a transcranial PBMT procedure in mice. This protocol is specifically targeted to neuroscience laboratories that perform photobiomodulation research focused on rodents. However, this protocol can be adapted to other laboratory animals that are frequently used in the neuroscience field, such as rabbit, cat, dog, or monkey.

Currently, there is increased interest in investigating transcranial PBMT with red/NIR lasers and LEDs. In order to successfully carry ou...

Access restricted. Please log in or start a trial to view this content.

Disclosures

P.C.'s salary was supported by the Harvard Psychiatry Department (Dupont-Warren Fellowship and Livingston Award), by the Brain and Behavior Research Foundation (NARSAD Young Investigator Award), and by the Photothera Inc. unrestricted grant. The drug donation came from TEVA. Travel reimbursement came from Pharmacia-Upjohn. P.C. has received consultation fees from Janssen Research and Development. P.C. has filed several patents related to the use of near-infrared light in psychiatry. PhotoMedex, Inc. supplied four devices for a clinical study. P.C. has received unrestricted funding from Litecure Inc. to conduct a study on transcranial photobiomodulation for the treatment of major depressive disorders and to conduct a study on healthy subjects. P.C. cofounded a company (Niraxx Light Therapeutics) focused on the development of new modalities of treatment based on near-infrared light; he is also a consultant for the same company. P.C. received funding from Cerebral Sciences to conduct a study on transcranial photobiomodulation for generalized anxiety disorder. The other authors have no conflicts of interest to disclose.

Acknowledgements

This work was supported by a grant from the Tabriz University of Medical Sciences (grant no. 61019) to S.S.-E. and a publication grant from LiteCure LLC, Newark, DE, USA to L.D.T. The authors would like to thank the Immunology Department and Education Development Center (EDC) of Tabriz University of Medical Sciences for their kind assistance.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
KetamineAlfasan#1608234-01
XylazineAlfasan#1608238-01
AgaroseSigma#A4679
SuperglueQuickstar
VibratomeCampden Instruments#MA752-707
Optical glassSail Brand#7102
Power meterThor labs#PM100D
Photodiode detectorThor labs#S121C
CaliperPittsburgh
GaAlAs laserThor Photomedicine
Etho VisionNoldus
CentrifugeFroilabo#SW14R
EarmuffsBlue Eagle
Digital cameraVisionlite#VCS2-E742H
Sterio amplifierSony
EthanolHamonteb#665.128321
Barnes mazeCostom-made
ATP assay kitSigma#MAK190
Elisa readerAwareness#Stat Fax 2100

References

  1. Chung, H., et al. The nuts and bolts of low-level laser (light) therapy. Annals of Biomedical Engineering. 40 (2), 516-533 (2012).
  2. Salehpour, F., et al. Brain Photobiomodulation Therapy: a Narrative Review. Molecular Neurobiology. , 1-36 (2018).
  3. Hamblin, M. R. Shining light on the head: photobiomodulation for brain disorders. BBA Clinical. 6, 113-124 (2016).
  4. Karu, T. I., Pyatibrat, L. V., Kolyakov, S. F., Afanasyeva, N. I. Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation. Journal of Photochemistry and Photobiology B: Biology. 81 (2), 98-106 (2005).
  5. de Freitas, L. F., Hamblin, M. R. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE Journal of Selected Topics in Quantum Electronics. 22 (3), 348-364 (2016).
  6. Xuan, W., Vatansever, F., Huang, L., Hamblin, M. R. Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice. Journal of Biomedical Optics. 19 (10), 108003(2014).
  7. DeTaboada, L., et al. Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers in Surgery and Medicine: The Official Journal of the American Society for Laser Medicine and Surgery. 38 (1), 70-73 (2006).
  8. De Taboada, L., et al. Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice. Journal of Alzheimer’s Disease. 23 (3), 521-535 (2011).
  9. Oueslati, A., et al. Photobiomodulation suppresses alpha-synuclein-induced toxicity in an AAV-based rat genetic model of Parkinson’s disease. PloS One. 10 (10), e0140880(2015).
  10. Xu, Z., et al. Low-level laser irradiation improves depression-like behaviors in mice. Molecular Neurobiology. 54 (6), 4551-4559 (2017).
  11. Salehpour, F., et al. Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose–induced aging mice. Neurobiology of Aging. 58, 140-150 (2017).
  12. Grady, C. The cognitive neuroscience of ageing. Nature Reviews Neuroscience. 13 (7), 491(2012).
  13. Beal, M. F. Mitochondria take center stage in aging and neurodegeneration. Annals of Neurology. Official Journal of the American Neurological Association and the Child Neurology Society. 58 (4), 495-505 (2005).
  14. Lu, Y., et al. Low-level laser therapy for beta amyloid toxicity in rat hippocampus. Neurobiology of Aging. 49, 165-182 (2017).
  15. Seibenhener, M. L., Wooten, M. C. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. Journal of Visualized Experiments. (96), e52434(2015).
  16. Rosenfeld, C. S., Ferguson, S. A. Barnes maze testing strategies with small and large rodent models. Journal of Visualized Experiments. (84), e51194(2014).
  17. Huang, Y. Y., Chen, A. C. H., Carroll, J. D., Hamblin, M. R. Biphasic dose response in low level light therapy. Dose Response. 7 (4), 358-383 (2009).
  18. Mohammed, H. S. Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats. Lasers in Medical Science. 31 (8), 1651-1656 (2016).
  19. Zhang, Y., Zhang, C., Zhong, X., Zhu, D. Quantitative evaluation of SOCS-induced optical clearing efficiency of skull. Quantitative Imaging in Medicine and Surgery. 5 (1), 136(2015).
  20. Shaw, V. E., et al. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. Journal of Comparative Neurology. 518 (1), 25-40 (2010).
  21. Moro, C., et al. Photobiomodulation inside the brain: a novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice. Journal of Neurosurgery. 120 (3), 670-683 (2014).
  22. Reinhart, F., et al. The behavioural and neuroprotective outcomes when 670 nm and 810 nm near infrared light are applied together in MPTP-treated mice. Neuroscience Research. 117, 42-47 (2017).
  23. Sadowski, M., et al. Amyloid-β deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. Journal of Neuropathology and Experimental Neurology. 63 (5), 418-428 (2004).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Laser TreatmentBarnes MazeHippocampal ATPSpatial MemoryAged MiceBrain TissueLight TransmissionVibratome Sectioning

Related Articles